Nature, Published online: 23 October 2026; doi:10.1038/d41586-026-03417-0
Long-awaited results from phase III trial show a huge benefit in treating treatment-resistant melanoma.General
Moderna mRNA vaccine almost halves the risk of skin cancer returning
Nature News0 views
Source:https://www.nature.com/articles/d41586-026-03417-0
PreviousNew iPhone Duo cases available for purchase: Fabric, leather, aramid fiber, metal, more [Updated]NextMIT scientists build a tiny robot that swims using living muscle cells
Related posts
Get 25 Percent Off My Favorite Renter-Friendly Storage Lockers
0Wired

The 16GB Raspberry Pi 5 got another ‘unavoidable’ RAM price hike
0The Verge
Do practice partners actually help when you start speaking Chinese?
0dev.to

How we halved DNS build delay and cut memory use by 85%
0Cloudflare Blog
Birdbuddy vs. Birdfy: Which Budget Smart Feeder Should You Buy? (2026)
0Wired
2 days till TechCrunch Founder Summit: Boston founders don’t need a Silicon Valley address to build something big
0TechCrunch